A RAND study published in the Journal of Medical Internet Research finds that telehealth usage soared during the early months of the COVID-19 pandemic, but it was behavioral health diagnoses largely driving the surge, not COVID-related...
A RAND study published in the Journal of Medical Internet Research finds that telehealth usage soared during the early months of the COVID-19 pandemic, but it was behavioral health diagnoses largely driving the surge, not COVID-related...
A meta-analysis and systematic review published in The Journal of Clinical Psychiatry supports the use of vesicular monoamine transporter 2 (VMAT2) inhibitors for the treatment of tardive dyskinesia (TD).
A meta-analysis and systematic review published in The Journal of Clinical Psychiatry supports the use of vesicular monoamine transporter 2 (VMAT2) inhibitors for the treatment of tardive dyskinesia (TD).
Once-daily valbenazine was effective and generally well tolerated in adults with tardive dyskinesia who took the drug for up to 48 weeks, according to a study published online in The Journal of Clinical Psychiatry.
“Results indicated...
Once-daily valbenazine was effective and generally well tolerated in adults with tardive dyskinesia who took the drug for up to 48 weeks, according to a study published online in The Journal of Clinical Psychiatry.
“Results indicated...
